发现了一种强大的CDKs/FLT3 PROTAC,可增强AML的分化和扩散抑制
Mingfei Wu1, Wei Wang2, Xinfei Mao2
1Hangzhou Institute of Innovative Medicine, Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, PR China.
European journal of medicinal chemistry
|June 15, 2024
概括
一种新型化合物C3有效地向和降解急性髓性白血病 (AML) 细胞中的关键蛋白质,促进细胞分化和抑制细胞增殖. 这项研究为AML治疗提供了一个有前途的新疗法策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药用化学 医学化学
背景情况:
- 急性髓性白血病 (AML) 是一种具有挑战性的血液性恶性瘤,其特征是未成熟的髓性原始细胞.
- 开发有效的AML治疗方法,诱导细胞分化并抑制增殖,仍然是一个至关重要的未满足需求.
- 之前的研究已经探索了循环林依赖激酶 (CDK) PROTACs,以寻找它们在AML中的诱导差异化潜力.
研究的目的:
- 从结构上优化PROTAC,以增强CDK的降解,从而促进AML细胞分化和抑制增殖.
- 研究一种新型化合物C3在降解标蛋白的有效性及其对AML细胞行为的影响.
- 评估C3对各种CDK和FMS类氨酸激酶3 (FLT3) 的降解选择性概况.
主要方法:
- 针对CDKs的PROTAC化合物的合成和结构优化.
- 在AML细胞系中使用DC50值评估化合物C3的CDK2降解效率.
- 评估C3在HL-60细胞中诱导细胞分化的能力.
- 在不同类型的AML细胞中分析C3的抗增殖活性.
- 对C3与CDK家族成员和FLT3的降解选择性分析,包括FLT3-ITD.
主要成果:
- 化合物C3证明了CDK2的强烈降解,DC50值较低 (18.73 ± 10.78 nM).
- 在6.25nM (72.77±3.51%) 的度下,C3显著刺激了HL-60细胞的细胞分化.
- C3对各种AML细胞系表现出强烈的抗增殖作用.
- 降解分析显示,C3具有降解CDK2/4/6/9和FLT3的能力,特别是在MV4-11细胞中的FLT3-ITD.
结论:
- 化合物C3有效降解CDK2,并诱导AML细胞的分化和增殖抑制.
- 由于C3能够同时准多个CDK和FLT3,因此为AML提供了一个有前途的多目标治疗策略.
- 这些发现支持C3作为治疗急性髓性白血病的潜在新型治疗剂.
相关概念视频
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K